|
Home
>
Newsletters
>
Drug Industry Daily
> Specification Concerns Prompt Recall, MHRA Alert on Sanofi Pasteur Typhoid Vaccine
Drug Industry Daily
Oct. 10, 2012
| Vol.
11 No.
199
Specification Concerns Prompt Recall, MHRA Alert on Sanofi Pasteur Typhoid Vaccine
Sanofi Pasteur MSD, a Merck-Sanofi vaccine venture, is recalling 16 batches of its typhoid vaccine Typhim Vi after recent investigations found some syringes may have sub-potent antigen levels, the Medicines and Healthcare products Regulatory Agency (MHRA) says.
|
|
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews
All rights reserved. Do not duplicate or redistribute in any form.